Biotechnology

Type: Keyphrase
Name: Biotechnology
First reported 7 mins ago - Updated 7 mins ago - 1 reports

Top Healthcare and Biotech Focused Hedge Funds Surge; Oversee $70 Billion in Equity Assets

The most recent Top 50 Healthcare, Pharmaceutical and Biotechnology Focused Hedge Fund list has been released, revealing that the top hedge funds now... ... [Published HedgeTracker - 7 mins ago]
First reported Apr 18 2014 - Updated 23 hours ago - 3 reports

The government must decide now on GMOs

Editorial CartoonFor years now Tanzania has been hesitant in allowing the country to adopt the widely touted Genetically Modified Organisms (GMOs).Although no official statement has been issued to bar farmers from adopting the biotechnology, the fear ... [Published IPP Media - 23 hours ago]
First reported Apr 18 2014 - Updated Apr 18 2014 - 2 reports

Pacific Northwest Venture Activity ‘Healthy’ in First Quarter

While venture capital investment in the first quarter nationally hit levels not seen since spring 2001, the Pacific Northwest started the year with a fairly typical level of funding and deals. Investors backed 30 companies in Washington and Oregon wi ... [Published BioPortfolio - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 2 reports

Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics: New Research Report Available at Fast Market Research

Boston, MA -- ( SBWIRE ) -- 04/18/2014 -- The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.Comprehensive directory ... [Published SBWire - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Selling Biotech: How We're Locking in Big Gains

My friend, it is time for me – and for my subscribers – to move on from biotech.   The ride has been fantastic. But it's now time to go.   Let me explain...   $10,000 would have turned into $44,000 in just over two years in biotech, if you'd followed ... [Published DailyMe.Com - Apr 18 2014]
Entities: Biotechnology
First reported Apr 18 2014 - Updated Apr 18 2014 - 2 reports

Less is more for VCs investing in biotech

Even in an off-quarter, biotech showed itself to be a key driver of New York's growing tech sector, and that momentum will need to continue in the face of stiff market headwinds.Venture-capital investment in medical and biotech startups dipped slightly ... [Published Crains NY Business - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 2 reports

Opportunities Among The Rubble Of The Biotech Selloff

The selloff in biotech stocks over the past month has hurt Justin Uyehara, one of my top managers who I think just might be one of our generations' Warren Buffetts. Justin's portfolio ... ... [Published Big News Network - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 2 reports

Alkermes CEO Richard Pops on Building Big and Playing Well with Pharma

How do you build a biotech? Ask ten CEOs and you’ll likely get a hundred answers, but for Richard Pops, CEO of Waltham, MA- and Dublin, Ireland-based Alkermes, it arguably boils down to this: deliberately. Pops took over Alkermes (NASDAQ: ALKS)...Related ... [Published BioPortfolio - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Biotech slump is buying opportunity

Biotechnology stocks are in a bear market. The Nasdaq Biotech index (NBI) has plunged by more than 20% since its record high in February.In April, of the index’s 121 stocks, only half a dozen or so “have managed to hold their heads above water”, say Rodrigo ... [Published Money Week - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Biotech VCs wager $1.1B in Q1, starting the year with a flurry of new deals

Venture investing in the biotech sector hit the $1.1 billion mark in the first quarter of the year--a surprisingly strong showing for what has generally been a quiet season in the U.S. industry.The MoneyTree Report, a production of PricewaterhouseCoopers ... [Published FierceBiotech - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 2 reports

Markets Rise In Asia

REUTERS/Paul BarkerGood morning! Things are very quiet and there's not that much going on due to the Good Friday holiday, which has all markets closed in Europe and the US.The only action of the day was in Europe, where things were generally positive ... [Published Business Insider - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Global Pharmaceutical & Biotechnology Outlook 2013: Rising Stars

-- Despite negative outcome of pivotal clinical trials or ruling by the FDA, no one (investors and large pharma/biotech companies) have given up on innovation which is reflected in the healthy cash position within the sector. Hope of resurrection will ... [Published Scoop Asia - Apr 18 2014]

Quotes

Google "really wants to pull together initially a very small group of people who have worldwide reputations" said George Geis, an adjunct professor who specializes in technology mergers and acquisitions at UCLA's Anderson School of Management...
Original Article: NEXT ARTICLE More From BioPortfolio on "News digest – lung cancer ‘Matrix’ trial, tumour goggles, 3D-printed cancer cells and more"
...As Paul Nowak, the TUC's assistant general secretary, argues: "Identifying key industries where government support could help emerging firms become world leaders, and encouraging UK companies to look for business opportunities within China's very detailed current five-year plan, would be a start."
Hickey predicts that the lost-momentum stocks won't come back until the Fed launches another round of quantitative easing, and that won't happen "until there is real damage. The Fed can't come in and save the markets just because Twitter has lost (a third) of its value when the market is down only 2 or 3 percent. It's going to take a double-digit decline that has impact on the economy."

More Content

All (33494) | News (30078) | Reports (3) | Blogs (2438) | Audio/Video (13) | Fact Sheets (327) | Press Releases (594)
sort by: Date | Relevance
Top Healthcare and Biotech Focused Hedge Funds ... [Published HedgeTracker - 7 mins ago]
Geneticist Cynthia Kenyon heading to Google [Published San Francisco Chronicle - 22 mins ago]
Software Is Dominating Venture Capital Investme... [Published Atlanta Journal And Constitution - 1 hour ago]
More women seize opportunities to start businesses [Published Pittsburgh Tribune Review - 1 hour ago]
Will Coggin: Don't be taken in by 'green' food ... [Published Lansing State Journal - 1 hour ago]
Marin Voice: Offerings continue to grow at IVC [Published Marin Independent Journal - 2 hours ago]
News digest – lung cancer ‘Matrix’ trial, tumou... [Published BioPortfolio - 2 hours ago]
Chromatography Instrumentation Market Worth $10... [Published Individual.com - 2 hours ago]
Advanced Chemistry Development celebrates 20 years [Published Labmate Online - 3 hours ago]
Addressing the structural forces that perpetuat... [Published BioPortfolio - 3 hours ago]
If Britain wants to become a nation of makers, ... [Published Guardian.co.uk - 3 hours ago]
Once high-flying stocks lose momentum, it's har... [Published San Francisco Chronicle - 4 hours ago]
Millennials win placements at top summer schools [Published Daily Times - 5 hours ago]
Software Is Dominating Venture Capital Investme... [Published Forbes.com - 5 hours ago]
Malaysia Airlines Flight MH370 search shows ext... [Published MaritimeSecurity.Asia - 6 hours ago]
Flamel Technologies: Great Buying Opportunity B... [Published BioPortfolio - 6 hours ago]
Nektar Fortifies Its Position In Advance Of The... [Published BioPortfolio - 6 hours ago]
Food Shortages Might Doom Humanity by 2050 [Published Jezebel - 6 hours ago]
Column: Building opportunities for MnSCU and state [Published Red Wing Republican Eagle - 6 hours ago]
The seed segment is our future growth area: Dav... [Published Sify - 7 hours ago]
I deserve to be in there Lisa Johnson on being ... [Published Big News Network - 7 hours ago]
This Week in Biotech: Diabetes Patients Chalk U... [Published Motley Fool Discussion Boards - 7 hours ago]
7 ways chronic illness imposes an extra burden ... [Published BioPortfolio - 7 hours ago]
4 Dow Stocks Under Accumulation [Published Forbes.com - 8 hours ago]
UGA BioBusiness Center helps turn discoveries i... [Published OnlineAthens - 8 hours ago]
Meet the Company That's Changing the Multiple S... [Published Motley Fool Discussion Boards - 8 hours ago]
Neuromodulation Market (Spinal Cord Stimulation... [Published PRWeb - 9 hours ago]
This Medical Marijuana Stock Is Not What You Think [Published Motley Fool Discussion Boards - 9 hours ago]
What physicians can do to curb over-the-counter... [Published BioPortfolio - 9 hours ago]
That North, South divide [Published Deccan Chronicle - 10 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Top Healthcare and Biotech Focused Hedge Funds ... [Published HedgeTracker - 7 mins ago]
The most recent Top 50 Healthcare, Pharmaceutical and Biotechnology Focused Hedge Fund list has been released, revealing that the top hedge funds now... ...
Malaysia Airlines Flight MH370 search shows ext... [Published MaritimeSecurity.Asia - 6 hours ago]
Skip to search. New User? Register Sign In Help Make Yahoo My Homepage Mail My Yahoo Yahoo Search Search Web Home Photos Ukraine Flight 370 Pot in Canada Pistorius Lottery Numbers Weather Most Popular Widescreen Video Canada World ...
Ethics in the Practice of Intellectual Property... [Published Patent Docs - 23 hours ago]
The John Marshall Law School Center for Intellectual Property, Information & Privacy Law will be holding a program on Ethics in the Practice of Intellectual Property Law on April 24, 2014 in Chicago, IL. The conference will consist of the following s ...
Medical Affairs Consortium Research Identifies ... [Published PR Newswire: General Business - Apr 19 2014]
CHAPEL HILL, N.C., April 18, 2014 /PRNewswire/ -- In today's highly competitive and demanding healthcare landscape, pharmaceutical, biotechnology and medical device companies greatly rely on thought leaders to influence the important decisions relevant ...
Software is eating the world, and venture capit... [Published Venturebeat - Apr 19 2014]
Image Credit: ~Aphrodite Marc Andreesen once said that “ software is eating the world ,” and this past quarter of venture capital investment sure seems to back that statement up. PricewaterhouseCoopers and the National Venture Capital Association ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Nasdaq suffers worst stampede since 2011 [Published Reuters Video: Top News - Apr 10 2014]
Nasdaq suffers worst stampede since 2011 [Published Reuters Video: Business - Apr 10 2014]
Techs tumble, IPOs sizzle, Jobs bounce [Published Reuters Video: Top News - Apr 04 2014]
Techs tumble, IPOs sizzle, Jobs bounce [Published Reuters Video: Business - Apr 04 2014]
Friday comeback for stocks [Published Reuters Video: Top News - Mar 28 2014]
1 2 3

Press Releases

sort by: Date | Relevance
Iconic Therapeutics Raises $20 Million to Advan... [Published Financial Services - Apr 16 2014]
Verde Media Biotech Division Secures Licensing ... [Published Financial Services - Apr 16 2014]
Momenta Pharmaceuticals Announces Date of First... [Published GlobeNewswire: Acquisitions News - Apr 15 2014]
NW BIO CLOSES ON FIRST $15 MILLION OF FINANCING... [Published Financial Services - Apr 15 2014]
Analysts View on Biotech Equities -- Research o... [Published Financial Services - Apr 15 2014]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.